1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow CVD: new trials by email Literature Review of CVD trials Research Report on CVD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Dapagliflozin 10mg - PreDiabetes, Myocardial Infarction | Phase 3 | Unknown | Hamad Medical Corporation | 576 | 2019-03-01 | 2019-01-03 |
Diabetes Mellitus, Type 2 (1) · Myocardial Infarction (1) · Prediabetic State (1)
Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1) · Metabolic Diseases (1) · Myocardial Ischemia (1) · Necrosis (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
dapagliflozin (1)
Qatar (1)
PMID 14578255, PMID 16644654, PMID 17315136, PMID 19490820, PMID 23668478, PMID 24631482, PMID 25425451, PMID 25739882, PMID 27679584, PMID 27814267, PMID 28096223, PMID 28428225, PMID 28615237, PMID 29227578